COMMUNIQUÉS West-GlobeNewswire

Caira Surgical Featured on Bloomberg Intelligence’s Vanguards of Health Care Podcast
05/02/2024
Podcast Highlights Caira’s Radar-Based Surgical Tracking and Its Potential for Orthopedic Surgery NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Caira ® Surgical , an innovator in robotic and navigated orthopedic surgery, [...]
Court ruling in favor of Safe in its action against Neo Medical
05/02/2024
Court ruling in favor of Safe in its action against Neo Medical Eragny-sur-Oise – France – February 5, 2024, 6pm CET . Safe SA (the “Company” ) announces that on January 26, 2024, the Paris Judicial Court found in favor [...]
La justice tranche en faveur de Safe dans son procès contre Neo Medical
05/02/2024
La justice tranche en faveur de Safe dans son procès contre Neo Medical Eragny-sur-Oise - France - le 5 février 2024 à 18h . Safe SA (la « Société ») annonce que l’arrêt rendu par la Cour d’Appel de Paris le 26 janvier [...]
Protect Pharmaceutical Corp.'s President, Ali Yildiz, Issues a Letter to Shareholders
05/02/2024
ISTANBUL, Turkey, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) President, Ali Yildiz, publishes his February 2024 corporate update letter to Company Shareholders as follows: "February 5, [...]
Texas Infant to Become Fifth Child to Receive Life-Saving Gene Therapy Treatment on U.S. Soil
05/02/2024
DALLAS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Sufyan Pashai, a 4-month-old from Dallas, will travel to Minnesota and become the fifth child to receive life-saving gene therapy treatment on U.S. soil for metachromatic [...]
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
05/02/2024
SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
05/02/2024
SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
AMN Healthcare Named One of America’s Greatest Workplaces for Diversity by Newsweek
05/02/2024
DALLAS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, has been recognized as one [...]
Inteleos and Credivera Partner to Revolutionize Global Healthcare Credentialing
05/02/2024
Digital Identities and Verifiable Credentials To Increase Customer Data Security ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking partnership, Inteleos a non-profit global healthcare certification [...]
Discoverer of the Klotho Gene and Pioneer in Longevity and Disease Prevention Dr. Makoto Kuro-o Joins Scientific Advisory Board of ADvantage Therapeutics
05/02/2024
Dr. Kuro-o to speak at Second Annual Entrepreneurship, Longevity and Biotech Conference Held in Boca Raton, Florida BOCA RATON, Fla. and VIENNA, Austria, Feb. 05, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, a [...]
ARS Pharmaceuticals to Present Positive Clinical Efficacy Data for neffy® (epinephrine nasal spray) at 2024 AAAAI Annual Meeting
05/02/2024
Six posters and oral presentations to be presented, including efficacy data for neffy from two distinct clinical studies in oral food challenge induced anaphylaxis and chronic urticaria patients 100% response rate with [...]
Curia Receives 2024 CDMO Leadership Award
05/02/2024
Curia recognized for its Service in the CDMO industry ALBANY, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a [...]
Canada-based Cinim included as part of international digital series, In Pursuit of Wellness
05/02/2024
Launched on January 18, 2024 this limited series looks at modern wellness practices that span generations and cultures around the world CALGARY, Alberta, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Today, Cinim (Canadian [...]
ProLynx announces initiation of Phase I/II clinical trial of its DNA-damaging agent PLX038 in patients with rare CNS tumors at the National Cancer Institute (NCI)
05/02/2024
SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. announced today that the first patient was treated with PLX038 (PEGylated SN-38) in a Phase I/II clinical trial for primary CNS tumors driven by MYC or MYCN [...]
Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meeting
05/02/2024
Company to Host Virtual Investor Webcast on Friday, February 23 at 8:00 a.m. ET WALTHAM, Mass. and BOULDER, Colo., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company [...]
Spectral AI Announces Publication of Letter to Shareholders
05/02/2024
DALLAS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach
05/02/2024
NEW YORK and SHANGHAI, China, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related diseases, signed a memorandum of [...]
Curia reçoit le CDMO Leadership Award 2024
05/02/2024
Curia est ainsi reconnue pour son service dans le secteur des organisations de développement et de fabrication sous contrat ALBANY, New York, 05 févr. 2024 (GLOBE NEWSWIRE) -- Curia, une organisation de développement et [...]
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
05/02/2024
NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]

Pages